To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5114 | Tg4-294-2 |
Potent and Selective Antagonist for Human EP2 Receptors
More description
|
|
| DCC5113 | tg4-292-1 |
Potent and selective nociceptin opioid receptor (NOP) agonist
More description
|
|
| DCC5112 | tg4-290-1 |
Potent and selective nociceptin opioid receptor (NOP) agonist
More description
|
|
| DCC5111 | Tg4-166 |
Potent and selective nociceptin opioid receptor (NOP) agonist
More description
|
|
| DCC5110 | Tg3-95-1 |
EP2 allosteric potentiator
More description
|
|
| DCC5109 | Tg2-in-3h |
Highly selective, potent, cell-permeable fluorescent irreversible tissue transglutaminase (TG2) inhibitor
More description
|
|
| DCC5108 | Tg-2112x |
Novel inhibitor of mitochondrial calcium uptake (#333333; font-family: "Open Sans", HelveticaNeue, "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 15px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight:
More description
|
|
| DCC5107 | Tg11-77 Hydrochloride |
Novel, Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist
More description
|
|
| DCC5106 | Tg101114 |
Novel inhibitor of T315I mutant enzyme, exhibiting reasonable in vivo efficacy in a xenograft mouse model harboring T315I
More description
|
|
| DCC5105 | Tg100948 |
Novel dual VEGFR/Src kinase inhibitor
More description
|
|
| DCC5104 | Tg-0205221 |
Novel potent SARS coronavirus (CoV) 3CL protease inhibitor (Ki = 53 nM)
More description
|
|
| DCC5103 | Tg-0054 |
Novel and Potent Stem Cell Mobilizer; Inhibitor of SDF-1α/CXCR4 binding
More description
|
|
| DCC5102 | Tfr4oht |
Cyclized tamoxifen analog, selective ER modulator (SERM)
More description
|
|
| DCC5101 | Tfmo-12 |
CNS-penetrant selective class IIa histone deacetylase (HDAC) inhibitor, exploiting the >100-fold selectivity over class I/IIb HDACs
More description
|
|
| DCC5100 | Tfmo-1 |
Novel cell-active, selective class IIa HDAC inhibitor
More description
|
|
| DCC5099 | Tfgf-18 |
Novel GSK-3β inhibitor, showing anti-neuroinflammatory effects in lipopolysaccharide (LPS) activation of spontaneously immortalized SIM-A9 microglial cells and of mouse cortical microglia, inhibiting LPS-induced production of nitric oxide and the proinfla
More description
|
|
| DCC5098 | Tfah-10n |
Novel multipotent anti-Alzheimer agent, selectively inhibiting human butyrylcholinesterase (BChE), having strong antioxidant activity and good β-amyloid (Aβ) anti-aggregation properties
More description
|
|
| DCC5097 | Tezosentan |
Novel endothelin (ET) receptor antagonist
More description
|
|
| DCC5096 | Texasin |
Potent and selective human leukocyte 5-lipoxygenase (5-LOX) inhibitor
More description
|
|
| DCC5095 | Texaline |
Antitubercular agent
More description
|
|
| DCC5094 | Tetrazanbigen |
Inducer of S phase arrest and apoptosis in hepatocellular carcinoma QGY-7701
More description
|
|
| DCC5093 | Tetracenomycin X |
Potent inhibitor of protein synthesis, inhibiting translation by binding within the ribosomal exit tunnel
More description
|
|
| DCC5092 | Tetrabromobisphenol A |
Activator of the hepatic interferon pathway in rats
More description
|
|
| DCC5091 | Tetrabenazine |
Reversible inhibitor of vesicular monoamine transporter 2, showing anti-chorea effect and decreasing uptake of monamines into synaptic vesicles, as well as depletion of monoamine storage
More description
|
|
| DCC5090 | Tet3.0 |
Mutually Orthogonal Bioorthogonal Amino Acid, Enabling Efficient Protein Dual-Labeling in Cells
More description
|
|
| DCC5089 | Terutroban Sodium |
Selective Thromboxane_receptor>thromboxane receptor antagonist
More description
|
|
| DCC5088 | Tertomotide |
Peptide vaccine, residues (611-626) of the human telomerase reverse transcriptase catalytic subunit (hTERT), for the treatment of solid cancers
More description
|
|
| DCC5087 | Tenidap Sodium |
COX/5-LOX inhibitor and cytokine-modulating anti-inflammatory agent
More description
|
|
| DCC5086 | Temoporfin |
Photosensitizing agent used in the treatment of squamous cell carcinoma of the head and neck, also showing activity agaimst COVID-19 Mpro
More description
|
|
| DCC5085 | Telmesteine |
Mucolitic agent, inhibiting activation of nuclear factor kappa-κB (NF-κB) by blocking phosphoinositide 3-kinase/protein kinase B (PI3K/Akt)/IκB kinase (IKK) activities, showing the anti-inflammatory properties on inflammation-associated skin diseases
More description
|
|